The role of iron in oxygen-mediated toxicities

Critical Reviews in Toxicology

Volumn 22, Issue 2, 1992, Pages 119-141

  Ryan, Timothy P ^a   Aust, Steven D ^a  

^a UTAH STATE UNIVERSITY   (United States)

Author keywords

Ceruloplasmin; Ferritin; Iron; Lipid peroxidation; Oxidative stress; Redox cycling

Indexed keywords

ALCOHOL; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CATALASE; CERULOPLASMIN; DEFEROXAMINE; DEFEROXAMINE MESYLATE; DOXORUBICIN; FERRITIN; IRON; OXYGEN; PROBUCOL; RAZOXANE;

ATHEROSCLEROSIS; BIOAVAILABILITY; CANCER; HUMAN; LIPID PEROXIDATION; NONHUMAN; OXYGEN TOXICITY; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; STRESS;

ARTERIOSCLEROSIS; BIOLOGICAL AVAILABILITY; FREE RADICALS; HUMAN; IRON; NEOPLASMS; OXIDATION-REDUCTION; OXYGEN; REPERFUSION INJURY; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026710009     PISSN: 10408444     EISSN: None     Source Type: Journal    
DOI: 10.3109/10408449209146308     Document Type: Article

References (126)

1. Oxidation states, redox potentials and spin states, in
2. Transition metals as catalysts of “autoxidation” reactions
3. The role of metal ions in the chemistry and biology of oxygen, in
4. Iron: an element well-fitted for its task?, in
5. Spin-state/sterochemical relationships in iron porphyrins: implications for the hemoproteins
6. Oxy-radicals and related species: their formation, lifetimes, and reactions
7. The role of iron in oxygen radical mediated lipid peroxidation
8. The oxidizing nature of the hydroxyl radical. A comparison with the ferryl ion (Fe O2+)
9. Role of iron in model lipid peroxidation systems, in
10. The mechanism of initiation of lipid peroxidation. Evidence against a requirement for an iron (II)-iron (III) complex
11. Role of free radicals and catalytic metal ions in human disease: an overview
12. The requirement for ferric in the initiation of lipid peroxidation by chelated ferrous iron
13. The role of iron in the initiation of lipid peroxidation, in
14. Ferritin and superoxide-dependent lipid peoxidation
15. An investigation into the role of hydroxyl radical in xanthine oxidase dependent lipid peroxidation
16. The multiple effects of ethylenediam-inetetraacetate in several model lipid peroxidation systems
17. The effects of (+)-1,2-bis(3,5-dioxo-piperzin-1-yl)propane (ADR-529) on iron catalyzed lipid peroxidation
18. Iron and iron-derived free radicals, in
19. Fenton reactions in lipid phases
20. Cytochrome c-catalyzed membrane lipid peroxidation by hydrogen peroxide
21. The requirement for iron (III) in the initiation of lipid peroxidation by iron (II) and hydrogen peroxide
22. An investigation into the mechanism of citrate-Fe+2-dependent lipid peroxidation
23. The involvement of iron in lipid peroxidation: importance of ferric to ferrous ratios in initiation
24. Delayed, ferrous iron dependent peroxidation of rat liver microsomes
25. Inhibition of superoxide and ferritin-dependent lipid peroxidation by ceruloplasmin
26. Dependence of intestinal iron absorption on the valency state of iron
27. An overview of current information on bioavailability of dietary iron to humans
28. The valency state of absorbed iron appearing in the portal blood and ceruloplasmin substitution
29. The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum
30. The physiology of transferrin and transferrin receptors
31. Hepatocytes and reticulocytes have different mechanisms for the uptake of iron from transferrin
32. Iron metabolism: the low-molecular-mass iron pool
33. Mitochondrial iron not bound in heme and iron sulfur centers
34. Prevalence of hemochromatosis among 11, 065 presumably healthy blood donors
35. Estimates of iron sufficiency in the U. S. population
36. Ferritin: structure, gene regulation, and cellular function in animals, plants, and microorganisms
37. Regulation of ferritin and transferrin receptor mRNAs
38. Translation of ferritin light and heavy subunit mRNAs is regulated by intracellular chelatable iron levels in rat hepatoma cells
39. Regulation of ferritin and heme oxygenase synthesis in rat fibroblasts by different forms of iron
40. Increased ferritin gene expression is associated with increased ribonucleotide reductase gene expression and the establishment of hydroxyurea resistance in mammalian cells
41. Mossbauer studies of beef heart aconitase: evidence for facile interconversions of iron sulfur clusters
42. Stimulation of neutrophils by tumor necrosis factor
43. Reduced biopterin as a cofactor in the generation of nitrogen oxides by murine macrophages
44. FAD and GSH participate in macrophage synthesis of nitric oxide
45. Nw-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine
46. Generation of EPR-detectable nitrosyl-iron complexes in tumor target cells cocultured with activated macrophages
47. Nitric oxide mediates iron release from ferritin
48. Tumor necrosis factor-α and in-terleukin 1-α regulate transferrin receptor in human diploid fibroblasts
49. Release of iron from ferritin and its role in oxygen radical toxicities
50. Radical-driven Fenton reactions: studies with paraquat, adriamycin, and anthraquinone 6-sulfonate and citrate, ATP, ADP, and pyrophosphate iron chelates
51. Paraquat and ferritin dependent lipid peroxidation
52. Reductive release of iron from ferritin by cation free radicals of paraquat and other bipyridyls
53. Effect of diquat on the distribution of iron in rat liver
54. Release of iron from ferritin by cardiotoxic anthracycline antibiotics
55. Protective effect of ICRF-187 on doxorubicin-induced cardiac and renal toxicity on spontaneously hypertensive (SHR) and normotensive (WKY) rats
56. Effect of ICRF-187 pretreatment against doxorubicin-induced delayed cardiotoxicity in the rat
57. Introduction role of lipid peroxidation and oxidative stress in alcohol toxicity
58. Prevention of the acute ethanol-induced fatty liver by the simultaneous administration of anti-oxidants
59. The role of lipid peroxidation and antioxidants in ethanol-induced lipid alterations
60. Lipid peroxidation in ethanol poisoning: a critical reconsideration
61. Alcohol ingestion, liver glutathione and lipoperoxidation, metabolic interrelations and pathological implications
62. Lipid peroxidation, iron mobilization, and radical generation induced by alcohol
63. Increased microsomal oxidation of hydroxyl radical scavenging agents and ethanol after chronic consumption of ethanol
64. Hydroxyl radical production and ethanol oxidation by liver microsomes isolated from ethanol-treated rats
65. Increased oxygen radical-dependent inactivation of metabolic enzymes by liver microsomes after chronic ethanol consumption
66. Lipid peroxidation as a mechanism of alcoholic liver injury: role of iron mobilization and microsomal induction
67. Oxygen radical generation by microsomes: role of iron and implications for alcohol metabolism and toxicity
68. The role of aldehyde oxidase in ethanol-induced hepatic lipid peroxidation in the rat
69. Ethanol potentiates doxorubicin-induced inhibition of cell survival in cultured Chinese hamster ovary cells
70. Hepatic and biliary levels of glutathione and lipid peroxides following iron overload in the rat: effect of simultaneous ethanol administration
71. Role of oxygen free radicals in carcinogenesis and brain ischemia
72. Central nervous system trauma and stroke. I. Biochemical considerations for oxygen radical formation and lipid peroxidation
73. Reperfusion injury
74. Free radicals and myocardial ischemia and reperfusion injury
75. Concepts related to the study of reactive oxygen and cardiac reperfusion injury
76. Free radical producing enzyme, xanthine oxidase, is undetectable in human hearts
77. The activity of xanthine oxidase in heart of pigs, guinea pigs, rabbits, rats, and humans
78. Effect of oxygen concentration on the formation of malondialdehyde-like material in a model of tissue ischemia and reox-ygenation
79. Post resuscitation iron delocalization and malondialdehyde production in the brain following prolonged cardiac arrest
80. Iron chelation prevents tissue injury following ischemia
81. Central nervous system trauma and stroke. II. Physiological and pharmacological evidence for involvement of oxygen radical and lipid peroxidation
82. The cholesterol controversy is over: why did it take so long?
83. Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity
84. Low density lipoprotein undergoes oxidative modification in vivo
85. Effects of reagent and cell-generated hydrogen peroxide on the properties of low density lipoprotein
86. Nonenzymatic oxidative cleavage of peptide bonds in apoprotein B-100
87. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids
88. A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein
89. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture
90. Interaction of 4-hydroxyno-nenal-modified low-density lipoproteins with the fibroblast apolipoprotein B/E receptor
91. Modification of human low density lipoprotein by the lipid peroxidation product 4-hydroxynonenaI
92. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition
93. Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phos-pholipase A2 mimics cell-mediated oxidative modification
94. Lipid hydroperoxide involvement in copper-dependent and independent oxidation of low density lipoproteins
95. Increased plasma and erythrocyte lipid peroxidation in hyperlipidemic individuals
96. Probable free radical effects on rat liver nuclei during early hepatocarcinogenesis with a choline-devoid low methionine diet
97. Mutagenesis by the autoxi-dation of iron with isolated DNA
98. Mutation spectrum of copper-induced DNA damage
99. Iron-catalyzed reactions may be responsible for the biochemical and biological effects of asbestos
100. Measurement and analysis of chemically changed mineral fibers after experiments in vitro and in vivo
101. Iron mobilization from asbestos by chelators and ascorbic acid
102. The role of iron in asbestos-induced damage to lipids and DNA
103. Body iron stores and the risk of cancer
104. The incorporation of iron into apoferritin as mediated by ceruloplasmin
105. Plasma ceruloplasmin: evidence for its presence in and uptake by heart and other organs of the rat
106. Purification and partial characterization ceruloplasmin receptors from rat liver endothelium
107. Iron incorporation into apoferritin: the role of apoferritin as a ferroxi-dase
108. Hydroxyl radical production during oxidative deposition of iron into ferritin
109. Identification of the ferroxidase centre in ferritin
110. Mechanism of ferritin iron uptake: activity of the Hicham and deletion mapping of the ferro-oxidase site
111. Vitro loading of apoferritin
112. Antioxidants, aging, and longevity, in
113. Vitamin E and lipid antioxidants in free-radical-initiated reactions, in
114. Inhibition of oxidation of methyl linoleate in solution by vitamin E and vitamin C
115. B˜-Carotine: an unusual type of lipid antioxidant
116. The antioxidants of human extracellular fluids
117. Inhibition of liver microsomal lipid peroxidation by 13-cis retanoic acid
118. Oxidants and human disease: some new concepts
119. Current status of iron chelation therapy with deferroxamine
120. Prooxidant action of desferoxamine: enhancement of alkaline phosphatase inactivation by interaction with ascorbate system
121. Protection against tissue damage in vivo by desferoxamine: what is its mechanism of action?
122. Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain
123. Probucol inhibits oxidative modification of low density lipoprotein
124. Determination of nonheme iron, total iron, and copper, in